Texas Senate and House leaders are directing lawmakers to study issues related to cannabis products and psychedelic therapy during the legislature’s interim in preparation for a new session scheduled to begin in early 2027.
Lt. Gov. Dan Patrick (R), who oversees the Senate, pushed to pass legislation last session to ban hemp THC products. The legislation was approved by lawmakers but was later vetoed by Gov. Greg Abbott (R).
But Patrick isn’t giving up. In his list of 2026 interim legislative charges released on Friday, he’s directing the Senate Health and Human Services Committee.
Under a heading titled, “Addressing Societal Impacts of THC Product Consumption,” the lieutenant governor charged the panel to “study the impact of THC on increased health care costs, mental health emergency detentions, and the risk of being diagnosed with a THC-induced psychotic disorder.”
The committee should “make recommendations to decrease health care and criminal justice costs,” the directive says.
Separately, House Speaker Dustin Burrows (R) is directing his chamber’s Public Health Committee to spend time before the next session monitoring the “implementation and associated rulemaking” for legislation enacted last year to support clinical trials aimed at developing the psychedelic ibogaine into a legal prescription medicine to
Read full article on Marijuana Moment
